Evidence map›Paper›PMID 30034541›Full record

ArticleTherapeutic advances in urology2018

Holmium laser

Giacomo Maria Pirola, Giovanni Saredi, Ricardo Codas Duarte, Lorraine Bernard, Andrea Pacchetti, Lorenzo Berti, Eugenio Martorana, Giulio Carcano, Lionel Badet, Hakim Fassi-Fehri

Open access · bronzeAbstract read
In one paragraph

Article in Therapeutic advances in urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Giacomo Maria PirolaDepartment of Urology, University of Modena and Reggio Emilia, Via del Pozzo 71, Modena, 41124, Italy.ORCID https://orcid.org/0000-0002-4209-8670
Giovanni SarediDepartment of Urology, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Ricardo Codas DuarteDepartment of Urology and Transplantation, Edouard Herriot Hospital, Lyon, France.
Lorraine BernardClinical Research Unit, Hospices Civils de Lyon, Lyon, France.
Andrea PacchettiDepartment of Urology, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Lorenzo BertiDepartment of Urology, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Eugenio MartoranaDepartment of Urology, University of Modena and Reggio Emilia, Modena, Italy.
Giulio CarcanoDepartment of Surgery, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Lionel BadetDepartment of Urology and Transplantation, Edouard Herriot Hospital, Lyon, France.
Hakim Fassi-FehriDepartment of Urology and Transplantation, Edouard Herriot Hospital, Lyon, France.
Ospedale di Circolo e Fondazione Macchi · ITHôpital Edouard Herriot · FRUniversity of Modena and Reggio Emilia · ITHospices Civils de Lyon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of our study was to compare perioperative and functional outcomes of two different prostatic laser enucleation techniques performed in two high-volume centers: 100 W holmium laser enucleation of the prostate (HoLEP) (Lyon, France) and 110 W thulium laser enucleation of the prostate (ThuLEP) (Varese, Italy). MATERIALS AND

methodsA nonrandomized, observational, retrospective and matched-pair analysis was performed on two homogeneous groups of 117 patients that underwent prostate laser enucleation in the HoLEP or ThuLEP centers between January 2015 and April 2017, following the classical 'three lobes' enucleation technique. The American Society of Anesthesiologists (ASA) score and prostate volume were the main parameters considered for matching the patients between the two groups. Patients on anticoagulant therapy, with documented detrusor hypoactivity or hyperactivity or with the finding of concurrent prostate cancer were excluded from the study. Follow up was assessed at 3, 6 and 12 months after surgery.

resultsMedian enucleation and morcellation time was 75.5 and 11.5 min, respectively, in the HoLEP group

conclusionBoth HoLEP (100 W) and ThuLEP (110 W) relieve lower urinary tract symptoms in a comparable way with high efficacy and safety, with negligible clinical differences.

Indexed as

endoscopic enucleation of the prostateholmium laser enucleation of the prostatematched-pair analysisthulium laser enucleation of the prostate

Identifiers

PMID30034541
PMCPMC6048626
OpenAlexW2805743811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.